Sr One Capital Management, LP Arcellx, Inc. Transaction History
Sr One Capital Management, LP
- $279 Million
- Q2 2025
A detailed history of Sr One Capital Management, LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 2,346,630 shares of ACLX stock, worth $171 Million. This represents 55.41% of its overall portfolio holdings.
Number of Shares
2,346,630
Previous 2,346,630
-0.0%
Holding current value
$171 Million
Previous $154 Million
0.38%
% of portfolio
55.41%
Previous 69.67%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
218Shares Held
49.1MCall Options Held
245KPut Options Held
885K-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$339 Million14.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.94MShares$287 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$273 Million20.45% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$256 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$221 Million4.37% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.19B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...